ROS and APPG on Osteoporosis and Bone Health Inquiry Report on Access to Medicines
An upcoming report from the All-Party Parliamentary Group (APPG) on Osteoporosis and Bone Health highlights the “critical need for system-wide reform” to address barriers to osteoporosis medication in the NHS, leaving millions of people at risk of life-threatening fractures.
Fractures caused by osteoporosis are preventable. A timely diagnosis and a treatment plan can prevent fractures. But there is an enormous treatment gap with two-thirds of people who need anti-osteoporosis medications missing out on them – around 90,000 people every year.…
Read more of this article
The All Party Parliamentary Group (APPG) for Osteoporosis and Bone Health published a report into the long-standing postcode lottery in the NHS for osteoporosis care. The report highlights the scale of under-diagnosis, under-treatment and missed opportunities in the NHS, with a blueprint for change. Implementation of the blueprint in England and Wales could save the NHS around £287m over five years – a return on investment of around 3:1 – according to the Royal Osteoporosis Society (ROS), which has supported the Inquiry.… 
by Ellie Davies, Acting Project Manager, Falls and Fragility Fracture Audit Programme (FFFAP)
On 30th November 2017, the National Osteoporosis Society published new Osteoporosis Standards and Vertebral Fractures Guidance for Health Professionals. The guidelines help health professionals provide the possible care for people with osteoporosis.
Read the 
On 10th July 2017, NICE issued a new Technology Appraisal (TA) for bisphosphonates which links the recommendations for drug treatments to advice on fracture risk assessment outlined in their earlier guidance. The TA is not intended to provide treatment thresholds but offers recommendations on cost-effective use of bisphosphonates when using fracture risk assessment as described in their guideline